Medexprim’s researchers and engineers are immersed daily in the world of science, a mindset indispensable to continue innovating and addressing tomorrow’s challenges for Medexprim, its partners, and, above all, the patients.
Our expert Mercedes Serra discusses here a publication by another team of researchers, confronted with the limited amount of medical imaging data available for training and validating deep learning, especially in the case of rare diseases. It also addresses the challenge of anonymizing patient data in medical imaging research using synthetic images.
